{"nct_id":"NCT06851858","title":"Efficacy, Safety and Tolerability of AZD6234 in Participants Living With Overweight or Obesity With Type 2 Diabetes Who Are on a Stable Dose of GLP-1 Receptor Agonist","status":"RECRUITING","status_verified_date":"2025-09","start_date":"2025-03-12","start_date_type":"ACTUAL","primary_completion_date":"2026-07-08","primary_completion_date_type":"ESTIMATED","completion_date":"2026-07-08","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["AZN"]}